What’s in the House’s Bills to Address the Opioid Crisis — and What’s Not |
STAT (06/21) – The House spent much of the last two weeks passing dozens of bills aimed at addressing the opioid crisis, an effort top lawmakers from both parties have long identified as a priority. Many are consensus proposals, though a few have generated controversy. Some are substantial in their scope, though many fund pilot programs or studies, or enact grants for which funding will expire within years. Read more
Further reading:
|
|
|
WHO Classifies 'Gaming Disorder' as Mental Health Condition |
CNN (06/18) - Watching as a video game ensnares their child, many a parent has grumbled about "digital heroin," likening the flashing images to one of the world's most addictive substances. Now, they may have backup: The World Health Organization announced "gaming disorder" as a new mental health condition included in the 11th edition of its International Classification of Diseases, released Monday. Read more |
|
|
FDA Approves First Generic Versions of Suboxone Sublingual Film, Which May Increase Access to Treatment for Opioid Dependence |
FDA (06/14) – The U.S. Food and Drug Administration today approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film (applied under the tongue) for the treatment of opioid dependence. “The FDA is taking new steps to advance the development of improved treatments for opioid use disorder, and to make sure these medicines are accessible to the patients who need them. That includes promoting the development of better drugs, and also facilitating market entry of generic versions of approved drugs to help ensure broader access,” said FDA Commissioner Scott Gottlieb, M.D. Read more |
|
|
|
|
First Ketamine Guidelines for Pain Released |
WEBMD (06/15) - New research shows that ketamine can be effective for treating pain, and could be an alternative to opioids. Ketamine has captured headlines recently as a possible treatment for severe depression and posttraumatic stress syndrome. Ketamine is also being used more in inpatient and outpatient settings to manage pain. Read more
Further reading:
|
|
|
Major Study of Drinking Will Be Shut Down |
THE NEW YORK TIMES (06/15) - An investigation at the National Institutes of Health concluded that the $100 million trial had been tainted by funding appeals to the alcohol industry. The extensive government trial was intended to settle an age-old question about alcohol and diet: Does a daily cocktail or beer really protect against heart attacks and stroke? Read more |
|
| Why use SASSI screening questionnaires: |
|
| |
- Identifies SUD – even when someone is reluctant to self-disclose. - Accurately identifies individuals likely to be abusing prescription medications. - Screens for multiple levels of severity. - Distinguishes likely SUD from other psychological disorders. - Useful in developing treatment plans and goals. - Available for adults, adolescents, and special populations. TRAINING AVAILABLE - NAADAC CEUs |
|
|
|
|
Wearable Device to Treat Opioid Withdrawal Symptoms Approved By FDA |
THE FIX (06/15) – The device can curb anxiety, irritability, depression and opiate cravings without narcotics, according to its manufacturer. The U.S. Food and Drug Administration (FDA) has cleared a wearable device (simply named “Drug Relief”) that reduces common opioid withdrawal symptoms, according to Markets Insider. Read more |
|
|
Daily Cannabis Use Is on the Rise in American Adults |
EUREKALERT! (06/20) - Cannabis use may be decreasing among teens, but a new study by researchers at Columbia University's Mailman School of Public Health showed that American adults have increasingly used cannabis daily since 2007. The findings are published online in the Journal of Studies on Alcohol and Drugs. Read more |
|
|
|
|
Stigma Hinders Response To Opioid Epidemic, Study Says |
THE FIX (06/11) - Stigma around addiction is beating back public support for well-studied harm reduction interventions like needle exchanges and safe injection facilities (SIFs), according to a new study published in Preventive Medicine. Read more |
|
|
This Is Why Xanax Is Blowing Up in America |
VICE (06/12) - It’s not exactly breaking news that Xanax has been having something of a moment. Famous musicians, at least until prominent voices like Lil Xan (yes, even him!) and Chance the Rapper began swearing off the stuff, have long been inclined to hype it. And Xanny bars have been touted across social media and even in old-school graffiti for some time now. The number of adults prescribed drugs in the class that includes Xanax (alprazolam)—known as benzodiazepines—rose by 67 percent between 1996 and 2013. Over the same period, the amount of these drugs that was actually dispensed more than tripled, according to a 2016 study. Read more |
|
|
Canada Just Legalized Marijuana. That Has Big Implications for US Drug Policy. |
VOC (06/21) - Canada has become the first wealthy nation in the world to fully legalize marijuana. The Senate approved Bill C-45, also known as the Cannabis Act, on Tuesday. The measure was already approved by the House of Commons, so the Senate’s approval means it’s now set to become law. Read more |
|
|
NAADAC's June Product Discount
|
|
|
|
Helping Heroin Users Have Healthier Babies |
MEDICAL XPRESS (06/19) - A safer treatment for pregnant heroin-dependent women has been investigated by researchers from the University of Western Australia. The medication naltrexone was found to reduce the risks associated with heroin use during pregnancy. Naltrexone fights the effects of opioid drugs such as heroin, preventing the 'high' or euphoria they bring on. Read more |
|
|
On the Frontlines of the Opioid Crisis: A Doctor's Experience |
PEW (06/08) – In an episode of Pew's "After the Fact" podcast entitled "Treating the Opioid Epidemic," Dr. Shawn Ryan, chief medical officer at BrightView, an outpatient addiction medicine practice based in Cincinnati, spoke about his work and issues surrounding treatment of opioid use disorder. This Q&A is drawn from his full interview. Read more |
|
No comments:
Post a Comment